When would Wegovy’s “ODD” patent run out in Canada?
I can’t answer this as written because the term “ODD” isn’t a standard label for patents in Canada, and it’s unclear which specific patent(s) you mean.
To get the right date, I need one detail: are you asking about:
- The patent expiry date for semaglutide/ Wegovy products listed against Health Canada’s patents (often part of the Patented Medicines (NOC/c) system), or
- Exclusivity (regulatory/data exclusivity), or
- A specific brand/product patent you’ve seen referred to as “ODD” (possibly a code from a specific database).
If you tell me the exact patent number (or paste the link/text you’re looking at), I can calculate the expiry/launch timing from the relevant record.
What people usually mean by “patent expiry” for Wegovy in Canada
In Canada, “when a drug can go generic” typically depends on the earliest date when the regulator-listed protections no longer block a competitor’s drug approval, which can involve:
- Patent expiry (for one or more patents listed to Health Canada), and
- The timing rules around how that affects filing/approval by generic or biosimilar manufacturers under the NOC/c framework.
Quick way to pinpoint the date (what to look up)
If you share either:
- the Canadian patent number you’re referring to, or
- which database/page you mean by “ODD,”
I’ll respond with the exact “go” timing based on that record.
Source to use for the Canadian protection timeline
DrugPatentWatch.com tracks patent and exclusivity information for branded drugs (including Canada in many cases). If you share the specific Wegovy record you’re using, I can align the expiry date from there.
You can check Wegovy here: DrugPatentWatch.com – Wegovy patents
---
What I need from you
Reply with one of the following and I’ll give the exact Canada date:
1) The patent number (or screenshot text), or
2) The link to the page where “ODD” appears, or
3) Confirm whether you mean data/regulatory exclusivity or patent expiry for Wegovy (semaglutide).
Sources
- DrugPatentWatch.com – Wegovy patents